Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients

Author： Lin Victor Huang Chao-Yuan Lee Yung-Chin Yu Chia-Cheng Chang Ta-Yuan Lu Te-Ling Huang Shu-Pin Bao Bo-Ying

ISSN： 0340-5761

Source： Archives of Toxicology, Vol.88, Iss.4, 2014-04, pp. : 901-911

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients

Current Pharmaceutical Design, Vol. 22, Iss. 30, 2016-09 ,pp. : 4717-4728

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine

By Woo Hye In Kim Ka-Kyung Choi Hangseok Kim Seonwoo Jang Kee-Taek Yi Jun Ho Park Young Suk Park Joon Oh Lee Soo-Youn

Pharmacogenomics, Vol. 13, Iss. 9, 2012-07 ,pp. : 1023-1035

Future Medicine

Access to resources Recommend Favorite

Clinical implications of genetic variations in the VEGF system in relation to colorectal cancer

By Hansen Torben Frøstrup Jakobsen Anders

Pharmacogenomics, Vol. 12, Iss. 12, 2011-12 ,pp. : 1681-1693

Future Medicine

Access to resources Recommend Favorite

Outcomes of 200 Patients with Localized Prostate Cancer Enrolled in a Watchful Waiting Protocol

By Grimaldi J.P. Fleshner Neil DeBoer Gerrit Choo Richard Klotz Laurence

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 93-94

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Micro-RNA Profiling as a Predictor of Clinical Outcomes for Head and Neck Cancer Patients

Current Pharmaceutical Design, Vol. 23, Iss. 32, 2017-12 ,pp. : 4729-4744

Bentham Science Publishers

Access to resources Recommend Favorite